105 related articles for article (PubMed ID: 19395995)
1. Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma.
Koshiba H; Hosokawa K; Kubo A; Tokumitsu N; Watanabe A; Honjo H
Int J Gynecol Cancer; 2009 Feb; 19(2):208-13. PubMed ID: 19395995
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients.
Zhao C; Wang A; Lu F; Chen H; Fu P; Zhao X; Chen H
Tumour Biol; 2017 Feb; 39(2):1010428317691000. PubMed ID: 28231727
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
Naik MU; Naik TU; Suckow AT; Duncan MK; Naik UP
Cancer Res; 2008 Apr; 68(7):2194-203. PubMed ID: 18381425
[TBL] [Abstract][Full Text] [Related]
4. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
Murakami T; Takasawa A; Takasawa K; Akimoto T; Aoyama T; Magara K; Saito Y; Ota M; Kyuno D; Yamamoto S; Hasegawa T; Saito T; Osanai M
Cancer Sci; 2021 Feb; 112(2):906-917. PubMed ID: 33185939
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
7. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
8. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
9. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of sulfatide, a sulfated glycolipid, in well-differentiated endometrial adenocarcinoma.
Sugiyama T; Miyazawa M; Mikami M; Goto Y; Nishijima Y; Ikeda M; Hirasawa T; Muramatsu T; Takekoshi S; Iwamori M
Int J Gynecol Cancer; 2012 Sep; 22(7):1192-7. PubMed ID: 22801032
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Liu S; DuPont NC; Pejovic T
Gynecol Oncol; 2013 Jul; 130(1):174-80. PubMed ID: 23578537
[TBL] [Abstract][Full Text] [Related]
13. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
[TBL] [Abstract][Full Text] [Related]
14. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
15. Urocortin expression is downregulated in human endometrial carcinoma.
Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human trophoblast cells with gland-like endometrial spheroids: a model system for trophoblast invasion.
Buck VU; Gellersen B; Leube RE; Classen-Linke I
Hum Reprod; 2015 Apr; 30(4):906-16. PubMed ID: 25662813
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
19. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
20. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
